Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GTF2H5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NCOA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GDI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCM3AP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MESDC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SLC25A51 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBXL8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FZD10-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
RXFP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM192A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FANCC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
REG3A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUDT12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL10RB-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NSD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TERF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on